Constitutive degradation of IkappaBalpha in human T lymphocytes is mediated by calpain - Wikidata - wikimedia - TriplyDB

Constitutive degradation of IkappaBalpha in human T lymphocytes is mediated by calpain

Constitutive degradation of IkappaBalpha in human T lymphocytes is mediated by calpain

http://www.wikidata.org/entity/Q24814316

about

Fibromodulin suppresses nuclear factor-kappaB activity by inducing the delayed degradation of IKBA via a JNK-dependent pathway coupled to fibroblast apoptosis A novel intracellular isoform of matrix metalloproteinase-2 induced by oxidative stress activates innate immunity Expression of calpain-calpastatin system (CCS) member proteins in human lymphocytes of young and elderly individuals; pilot baseline data for the CALPACENT project.Nuclear factor-κB signaling contributes to mechanical ventilation-induced diaphragm weakness*A novel role for the proteasomal chaperone PSMD9 and hnRNPA1 in enhancing IκBα degradation and NF-κB activation - functional relevance of predicted PDZ domain-motif interaction.Protective effects of PARP inhibitor, PJ34, is related to down-regulation of calpain and NF-κB in a mouse model of TBI.Protective Effects of Calpain Inhibition on Neurovascular Unit Injury through Downregulating Nuclear Factor-κB-related Inflammation during Traumatic Brain Injury in Mice.

P2860

Q28386926-16F94FB5-54E8-4053-AD15-E858ABC7C1A2 Q28590127-F380B0CB-3820-42B7-BFF1-392533B98274 Q30654017-0C85EDA3-98FB-401F-BC9D-ED869D2871EF Q37205760-A190CC5E-12A2-48A5-8A87-0ABEBBD23871 Q39005586-A84CD121-0C28-4DCD-9268-444260917218 Q39817883-0095E9AE-9F23-4738-BAF7-4F16828B4C9B Q42053602-422AFE70-CA9D-448D-A4D6-672BF3EA7267

P2860

Constitutive degradation of IkappaBalpha in human T lymphocytes is mediated by calpain

http://www.wikidata.org/entity/Q24814316

description

2005 nî lūn-bûn

@nan

2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Constitutive degradation of IkappaBalpha in human T lymphocytes is mediated by calpain

@ast

Constitutive degradation of IkappaBalpha in human T lymphocytes is mediated by calpain

@en

Constitutive degradation of IkappaBalpha in human T lymphocytes is mediated by calpain

@nl

type

label

Constitutive degradation of IkappaBalpha in human T lymphocytes is mediated by calpain

@ast

Constitutive degradation of IkappaBalpha in human T lymphocytes is mediated by calpain

@en

Constitutive degradation of IkappaBalpha in human T lymphocytes is mediated by calpain

@nl

prefLabel

Constitutive degradation of IkappaBalpha in human T lymphocytes is mediated by calpain

@ast

Constitutive degradation of IkappaBalpha in human T lymphocytes is mediated by calpain

@en

Constitutive degradation of IkappaBalpha in human T lymphocytes is mediated by calpain

@nl

P1433

Q24814316-908E1FA4-0F4B-4012-AD0A-C179BF0575F2

P1476

Q24814316-04D57DA0-5A03-4F24-B476-0D225044F9EE

P2093

Q24814316-1E1304DB-FFCA-4B9F-AEE3-E97950D3443B

Q24814316-3EA80EF1-D541-4EF7-9D76-DD6230A9E647

Q24814316-68E5B0CB-34F0-49AB-842A-34EC49ACB556

P2860

Q24814316-010D85D8-EE01-4D88-9A5A-C2D0C2156047

Q24814316-0607D25B-1A3A-42DC-96A8-BEA596F9E82D

Q24814316-0D818FD7-2B78-4321-BCEA-04396E7A6353

Q24814316-525B17C2-2C5F-4EED-AA6E-B9D047BE9794

Q24814316-57734B65-B7EF-4C61-AF22-AA617FA0A078

Q24814316-98A330BD-C407-4FA0-BCDA-BD2B9DCDBD9B

Q24814316-A291AED6-FD45-4EA3-9733-515ECAC66523

Q24814316-A80DBD26-BCE4-44BA-AC2F-72F8F1659290

Q24814316-A9CC517A-7AF5-4904-A115-B95A2AE18A08

Q24814316-BA79E06D-FB04-431D-8ABC-E6B0095551C2

P2888

Q24814316-F04BC8F2-CC47-4996-B950-5D3BB80859D2

P304

Q24814316-2D14D421-BC9C-468D-83E1-119024AA12B5

P31

Q24814316-486545BE-6B5E-429F-9887-E94200A775D5

P356

Q24814316-F5577B25-C100-44FB-949B-781665632EBC

P407

Q24814316-1CF3CA91-AA43-40E3-BA3B-949E43A8F517

P433

Q24814316-70C296D2-7341-40A1-A892-4579B77AA5E0

P478

Q24814316-DC13D20C-1467-4B68-9136-51A63CAF9904

P577

Q24814316-847C4D27-E660-4F51-87DA-EA6092D35FC7

P5875

Q24814316-10C81FB0-7233-4A07-BDAD-80DE0EC3941E

P6179

Q24814316-B8EAEF47-F34D-4523-AE12-9A066E27CD63

P698

Q24814316-DDA73966-A090-4750-AB1B-3B39D40DB3F9

P932

Q24814316-72D87FD7-BE10-4072-AFAA-8A6D9BDAA3FD

P356

P1433

Immunity and Ageing

P1476

Constitutive degradation of IkappaBalpha in human T lymphocytes is mediated by calpain

@en

P2093

Sarah J Cullen

http://www.w3.org/2001/XMLSchema#string

Subramaniam Ponnappan

http://www.w3.org/2001/XMLSchema#string

Usha Ponnappan

http://www.w3.org/2001/XMLSchema#string

P2860

The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction

Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation

Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway

Signaling to NF-kappaB

The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation

The IKK complex: an integrator of all signals that activate NF-kappaB?

A nuclear export signal in the N-terminal regulatory domain of IkappaBalpha controls cytoplasmic localization of inactive NF-kappaB/IkappaBalpha complexes.

Hepatitis C virus NS5A and subgenomic replicon activate NF-kappaB via tyrosine phosphorylation of IkappaBalpha and its degradation by calpain protease.

A mechanistic insight into a proteasome-independent constitutive inhibitor kappaBalpha (IkappaBalpha) degradation and nuclear factor kappaB (NF-kappaB) activation pathway in WEHI-231 B-cells.

Constitutive nuclear factor-kappaB activity is crucial for human retinoblastoma cell viability.

P2888

P304

15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1742-4933-2-15

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2005-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7497287

http://www.w3.org/2001/XMLSchema#string

P6179

1018260494

http://www.w3.org/2001/XMLSchema#string

P698

16271147

http://www.w3.org/2001/XMLSchema#string

P932

1298323

http://www.w3.org/2001/XMLSchema#string